JINARC tolvaptan 30 mg + 60 mg tablet blister composite pack

Otsuka Australia Pharmaceutical Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ffcba623f6f4521b
Product Name: JINARC tolvaptan 30 mg + 60 mg tablet blister composite pack
Artg Id: 272788
Artg Name: JINARC tolvaptan 30 mg + 60 mg tablet blister composite pack
Sponsor: Otsuka Australia Pharmaceutical Pty Ltd
Company Detail Path: /organization/otsuka-australia-pharmaceutical-pty-ltd
Artg Date: 2017-03-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/0a971f77cbc9038a94c893e3cdb4bd41.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/4fa73bea8f6f74b1ed8587eae6984f2f.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

ffcba623f6f4521b

Type

Standard